Best Peptides for Liver Health
Peptides studied for metabolic dysfunction-associated steatohepatitis (MASH) and liver fat reduction.
Top Peptides for Liver Health
| Peptide | Evidence | Notes | Actions |
|---|---|---|---|
| SurvodutideTop Choice Survodutide (BI 456906) is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim in partnership with Zealand Pharma. It is being developed primarily for metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) and obesity. Survodutide's glucagon receptor activation promotes hepatic fat mobilization, making it uniquely suited for liver-related metabolic conditions. | high | Phase 2 MASH trial: 83% MASH resolution (4.8 mg) and 87% (6 mg) at 48 weeks, with fibrosis improvement in up to 52% of patients. |
Survodutide (BI 456906) is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim in partnership with Zealand Pharma. It is being developed primarily for metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) and obesity. Survodutide's glucagon receptor activation promotes hepatic fat mobilization, making it uniquely suited for liver-related metabolic conditions.
Phase 2 MASH trial: 83% MASH resolution (4.8 mg) and 87% (6 mg) at 48 weeks, with fibrosis improvement in up to 52% of patients.